Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Nautilus Biotechnology, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1
Revenues  0.00.00.00.0
Cost of goods sold  0.00.00.010.1
Gross profit  0.00.00.0-10.1
Selling, general and administrative   [+]25.921.13.31.6
Research and development  37.729.412.4 
Other operating expenses    -0.3-2.6
EBITDA   [+]-62.4-49.5-14.8 
Depreciation and amortization  1.21.00.7 
EBIT   [+]-63.6-50.5-15.5-9.1
Interest income  5.80.3  
Other income (expense), net   [+]-0.1-0.1-0.1-0.5
Pre-tax income  -57.9-50.3-15.6-9.6
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -57.9-50.3-15.6-9.6
   
Basic EPS   [+]($0.46)($0.60)($0.54)($1.59)
Diluted EPS   [+]($0.46)($0.60)($0.54)($1.59)
   
Shares outstanding (basic)   [+]124.684.529.16.1
Shares outstanding (diluted)   [+]124.684.529.16.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy